Back close

Multi-gene Testing in Neurological Disorders Showed an Improved Diagnostic Yield: Data from Over 1000 Indian Patients.

Publication Type : Journal Article

Thematic Areas : Medical Sciences

Publisher : J Neurol

Source : J Neurol (2019)

Campus : Kochi

School : School of Medicine

Department : Paediatrics, Community Medicine

Year : 2019

Abstract : BACKGROUND: Neurological disorders are clinically heterogeneous group of disorders and are major causes of disability and death. Several of these disorders are caused due to genetic aberration. A precise and confirmatory diagnosis in the patients in a timely manner is essential for appropriate therapeutic and management strategies. Due to the complexity of the clinical presentations across various neurological disorders, arriving at an accurate diagnosis remains a challenge. METHODS:We sequenced 1012 unrelated patients from India with suspected neurological disorders, using TruSight One panel. Genetic variations were identified using the Strand NGS software and interpreted using the StrandOmics platform.

RESULTS: We were able to detect mutations in 197 genes in 405 (40%) cases and 178 mutations were novel. The highest diagnostic rate was observed among patients with muscular dystrophy (64%) followed by leukodystrophy and ataxia (43%, each). In our cohort, 26% of the patients who received definitive diagnosis were primarily referred with complex neurological phenotypes with no suggestive diagnosis. In terms of mutations types, 62.8% were truncating and in addition, 13.4% were structural variants, which are also likely to cause loss of function.

CONCLUSION: In our study, we observed an improved performance of multi-gene panel testing, with an overall diagnostic yield of 40%. Furthermore, we show that NGS (next-generation sequencing)-based testing is comprehensive and can detect all types of variants including structural variants. It can be considered as a single-platform genetic test for neurological disorders that can provide a swift and definitive diagnosis in a cost-effective manner.

Cite this Research Publication : A. Ganapathy, Mishra, A., Soni, M. Rani, Kumar, P., Sadagopan, M., Kanthi, A. Vittal, Patric, I. Rosetta Pi, Sobha George, Sridharan, A., Thyagarajan, T. C., Aswathy, S. L., Vidya, H. K., Chinnappa, S. M., Nayanala, S., Prakash, M. B., Raghavendrachar, V. G., Parulekar, M., Gowda, V. K., Dr. Sheela Nampoothiri, Menon, R. N., Pachat, D., Udani, V., Naik, N., Kamate, M., A Devi, R. Rama, Kunju, P. A. Mohammed, Nair, M., Hegde, A. Udwadia, M Kumar, P., Sundaram, S., Tilak, P., Puri, R. D., Shah, K., Sheth, J., Hasan, Q., Sheth, F., Agrawal, P., Katragadda, S., Veeramachaneni, V., Chandru, V., Hariharan, R., and Mannan, A. U., “Multi-gene Testing in Neurological Disorders Showed an Improved Diagnostic Yield: Data from Over 1000 Indian Patients.”, J Neurol, 2019.

Admissions Apply Now